Published within
|«
«
|
...
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Company Profile
|
Vectura Group (Vectura or 'the group') is engaged in the development of inhaled therapies for the treatment of respiratory diseases. The group operates in the UK, where it is headquartered in Wiltshire. Vectura employed 209 people as of March 31, 2012.
Published By MarketLine
|
07 Mar 2013 |
$175
|
Company Profile
|
Vertex Pharmaceuticals Incorporated (Vertex or 'the company') is a commercial-stage biotechnology company engaged in the discovery, development and commercialization of small molecule drugs for the treatment of major diseases such as viral infections, cystic fibrosis, inflammation, autoimmune disorders and cancer. The company operates in the US. It is headquartered in Cambridge, Massachusetts and employed 2,000 people as of December 31, 2011.
Published By MarketLine
|
28 Aug 2012 |
$175
|
Company Profile
|
ViroPharma Incorporated (ViroPharma or 'the company') is a global biotechnology company dedicated to the development and commercialization of products that address serious diseases. The company operates in the US, Belgium, Canada, France, Italy, Germany, Spain, Switzerland and the UK. It is headquartered in Exton, Pennsylvania and employed 311 people as of December 31, 2011.
Published By MarketLine
|
11 Jan 2013 |
$175
|
Company Profile
|
Vivus (or 'the company') is a biopharmaceutical company focused on research, development and commercialization of products in the areas of sexual health, obesity and diabetes. The company primarily operates in the US. Vivus is headquartered in Mountain View, California, and employed 38 people as of February 17, 2012.
Published By MarketLine
|
18 Jan 2013 |
$175
|
Company Profile
|
Warner Chilcott Public Limited Company (WCRX or 'the company') is a leading provider of specialty branded pharmaceuticals primarily in women's healthcare, gastroenterology, urology and dermatology segments. The company primarily operates in the US and Western Europe. It is headquartered in Dublin, Ireland, and employed 2,100 people as of December 31, 2012.
Published By MarketLine
|
07 Jun 2013 |
$175
|
Company Profile
|
ZymoGenetics, a wholly-owned subsidiary of Bristol-Myers Squibb, is a biopharmaceutical company focused on discovering, developing and commercializing therapeutic protein-based products for the treatment of human diseases. The company's therapeutic emphasis is on the areas of hemostasis inflammatory diseases, cancer and viral infections. It primarily operates in the US. The company is headquartered in Seattle, Washington and employed 323 people as of December 2009.
Published By MarketLine
|
28 Apr 2011 |
$175
|
|«
«
|
...
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.